Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation

Biochemical and Biophysical Research Communications

Volumn 346, Issue 3, 2006, Pages 721-726

  Stentz, Frankie B ^a   Kitabchi, Abbas E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cytokines; Human endothelial cells; Insulin receptor; Oxidative stress; Palmitic acid; T lymphocytes; Unsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CD69 ANTIGEN; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LINOLEIC ACID; LINOLENIC ACID; LIPID; OLEIC ACID; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNSATURATED FATTY ACID;

AORTA; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; INSULIN RESPONSE; LIPID PEROXIDATION; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; T LYMPHOCYTE;

AORTA; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LINOLEIC ACID; LIPID PEROXIDATION; LYMPHOCYTE ACTIVATION; PALMITIC ACID; REACTIVE OXYGEN SPECIES; RECEPTOR, INSULIN; T-LYMPHOCYTES;

EID: 33745194553     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.159     Document Type: Article

References (37)

1. Helderman J.H. Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J. Clin. Invest. 67 (1981) 636-1642
2. Brown T.J., Ercolani L., and Ginsberg B.H. Properties and regulation of the T-lymphocyte receptors. J. Recept. Res. 3 (1983) 481-494
3. Ercolani L., Lin H.L., and Ginsberg B.H. Insulin-induced desensitization at the receptor and postreceptor level in mitogen-activated T-lymphocytes. Diabetes 34 (1985) 931
4. Buffington C.K., El-Shiekh T., Kitabchi A.E., and Matteri R. Phytohemagglutinin (PHA) activated human T-lymphocytes: concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH). Biochem. Biophys. Res. Commun. 134 (1986) 412-419
5. Stentz F.B., and Kitabchi A.E. De Novo emergence of growth factor receptors in activated human CD4+ and CD8+ T-lymphocytes. Metabolism 53 (2004) 17-122
6. Stentz F.B., and Kitabchi A.E. Transcriptome and Proteome expression in activated CD4 and CD8 in human T-lymphocytes. Biochem. Biophys. Res. Commun. 324 (2004) 692-696
7. Kitabchi A.E., Stentz F.B., and Umpierrez G.E. Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem. Biophys. Res. Commun. 315 (2004) 404-407
8. Stentz F.B., Umpierrez G.E., Cuervo R., and Kitabchi A.E. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53 (2004) 2079-2086
9. Stentz F.B., and Kitabchi A.E. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem. Biophys. Res. Commun. 335 (2005) 491-495
10. King G.L., and Brownlee M.B. The cellular and molecular mechanisms of diabetic complications. Endocrinol. Metab. Clin. North Am. 25 (1996) 225-270
11. Gosmanov A.R., Stentz F.B., and Kitabchi A.E. De Novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E516-E522
12. Creager M.A., Lüscher T.F., Cosentino F.C., and Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108 (2003) 1527-1532
13. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilatation in humans in vivo. Circulation 97 (1998) 1695-1701
14. Vaidyula V.R., Rao A.K., Mozzoli M., Homko C., Cheung P., and Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55 (2006) 202-208
15. Brownlee M.B. Mechanism of hyperglycemic damage in diabetes. In: Skyler J.S. (Ed). Atlas of Diabetes. second ed. (2006), Lippincott, Williams and Wilkins, Philadelphia 125-137
16. Stentz F.B., and Kitabchi A.E. Activated T-lymphocytes in type 2 diabetes: implications from in vitro studies. Current Drug Targets 4 (2003) 493-503
17. Grundy S.M., and Denke M.A. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31 (1990) 1149-1172
18. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., and Shulman G.I. Mechanism of free fatty acid-induced resistance in humans. J. Clin. Invest. 97 (1996) 2859-2865
19. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 (1997) 3-10
20. Steinberg H.O., Tarshoby M., Monestel R., Hook G., Cronin J., Johnson A., Bayazeed B., and Baron A.D. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilatation. J. Clin. Invest. 100 (1997) 1230-1239
21. Kitabchi A.E., Challoner D.R., and Williams R.H. Respiration and lipid peroxidation in tocopherol deficient rat heart. Proc. Soc. Exp. Biol. Med. 127 (1968) 647-650
22. Charron M.J., Brosius III F.C., Alper S.L., and Lodish H.F. A glucose transport protein expressed predominately in insulin-responsive tissues. Proc. Natl. Acad. Sci. USA 86 (1989) 2535-2539
23. Kaiser N., Sasson S., Feener E.P., Boukobza-Vardi N., Higashi S., Moller D.E., Davidheiser S., Przybylski R.J., and King G.L. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42 (1993) 80-89
24. Keys A., Anderson J.T., and Grande F. Serum cholesterol response to changes in diet IV particular saturated fatty acids in the diet. Metabolism 14 (1965) 776-787
25. Hegsted D.M., McGandy R.B., Myers M.L., and Stare F.J. Quantitative effects of dietary fat on serum cholesterol in man. Am. J. Clin. Nutr. 17 (1965) 281-295
26. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., and Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1 associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103 (1999) 253-259
27. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., and White M.F. Free fatty acid induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
28. Kashyap A., Belfort R., Gastaldelli A., Pratipanawatr T., Berria R., Pratipanawatr W., Bajaj M., Mandarino L., DeFronzo R., and Cusi K. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52 (2003) 2461-2474
29. Inoguchi T., Umeda L.P., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase c-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
30. Wolf B.A., Williamson J.R., Eason R.A., Chang K., Sherman W.R., and Turk J. Diacyl glycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J. Clin. Invest. 83 (1991) 31-38
31. Brand M.D. The efficiency and plasticity of mitochondrial energy transduction. Biochem. Soc. Trans. 33 (2005) 897-904
32. Duval C., Negre-Salvayre A., Dogilo A., Salvayre R., Penicaud L., and Casteilla L. Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 murine endothelial cells. Biochem. Cell Biol. 80 (2002) 747-764
33. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
34. Hertzel A.V., and Bernlohr A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol. Metab. 11 (2000) 175-180
35. Kotarsky K., Nilsson N.E., Flodgren E., Owman C., and Olde B. A human cell surface receptor activated by free fatty acids and thiazoldinedione drugs. Biochem. Biophys. Res. Commun. 301 (2003) 406-410
36. Oneill B.T., and Abel E.D. Akt1 in the cardiovascular system: friend or foe. J. Clin. Invest. 115 (2005) 2059-2063
37. Selye H. The general adaptation syndrome and the disease of adaptation. J. Clin. Endocrinol. 6 (1946) 117-230